Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor

Molecular Pharmacology

Volumn 59, Issue 5, 2001, Pages 1051-1060

  Arias, Hugo R ^a   Mccardy, Elizabeth A ^a   Blanton, Michael P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET; DIZOCILPINE; ETHIDIUM; ION CHANNEL; MEPACRINE; NICOTINIC RECEPTOR; PIPERIDINE DERIVATIVE; RADIOLIGAND;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; FLUORESCENCE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; STOICHIOMETRY;

EID: 0035027558     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.5.1051     Document Type: Article

References (37)

1. MK-801 inhibition of nicotinic acetylcholine receptor channels
2. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor
3. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor
4. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor
5. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors
6. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors
7. Transverse localization of the quinacrine binding site on the Torpedo acetylcholine receptor
8. Quinacrine and ethidium bind to different loci on the Torpedo acetylcholine receptor
9. The 'calcium antagonist' TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, noncompetitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes
10. Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state
11. 125I]TIDPC/16
12. Effect of MK-801 at the human α7 nicotinic acetylcholine receptor
13. Open-channel blockers at the human α4/β2 neuronal nicotinic acetylcholine receptor
14. Allosteric receptors after 30 years
15. 50) of an enzymatic reaction
16. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis
17. 3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor
18. On the mechanism of inhibition of the nicotinic acetylcholine receptor by the anticonvulsant MK-801 investigated by laser-pulse photolysis in the microsecond-to-millisecond time region
19. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: A voltage clamp study on neuronal cells in culture
20. Distance between the agonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor
21. Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801
22. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor
23. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: Relevance to their toxicities
24. General anesthetic actions on ligand-gated ion channels
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Aminotriarylmethane dyes are high-affinity noncompetitive antagonists of the nicotinic acetylcholine receptor
27. 3H]tetracaine, a nondesensitizing noncompetitive antagonist
28. Evolutionary history of the ligand-gated ion-channel superfamily of receptors
29. Location of ligand binding sites on the nicotinic acetylcholine receptor α subunit
30. 3H]ethidium diazide within the Torpedo nicotinic acetylcholine receptor ion channel
31. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels
32. The attractions of proteins for small molecules and ions
33. pAx and competitive drug antagonism
34. 3 receptor
35. Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine
36. Quinacrine binds to the lipid-protein interface of the Torpedo acetylcholine receptor: A fluorescence study
37. Subunit-dependent inhibiton of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics and dizocilpine